Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

28.2K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
28.2K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

5.7K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
5.7K
Embryonic Stem Cells00:58

Embryonic Stem Cells

32.7K
Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
32.7K
Embryonic Stem Cells00:57

Embryonic Stem Cells

5.3K
Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
5.3K
Adult Stem Cells01:33

Adult Stem Cells

33.9K
Stem cells are undifferentiated cells that divide and produce more stem cells or progenitor cells that differentiate into mature, specialized cell types. All the cells in the body are generated from stem cells in the early embryo, but small populations of stem cells are also present in many adult tissues including the bone marrow, brain, skin, and gut. These adult stem cells typically produce the various cell types found in that tissue—to replace cells that are damaged or to continuously...
33.9K
Intrinsically Disordered Proteins02:18

Intrinsically Disordered Proteins

19.6K
Intrinsically disordered proteins are a group of proteins that do not fold into specific three-dimensional structures. Their structural flexibility allows them to complement ordered proteins to perform functions that are inaccessible to rigid structures. They are more common in eukaryotes than prokaryotes and may either be exclusively intrinsically disordered or hybrid proteins, consisting of a mix of ordered and disordered regions. The absence of a rigid structure in these proteins can be...
19.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Resuscitation during robotic-assisted pelvic surgery: impact of simulation training and system-specific factors.

Journal of robotic surgery·2026
Same author

Scalable CAR-T production in a 2-litre perfusion stirred-tank bioreactor with automated harvesting and scale-down model characterisation.

Frontiers in bioengineering and biotechnology·2026
Same author

Optimising and adapting perfusion feeds in serum-free medium to intensify CAR-T cell expansion in stirred-tank bioreactors.

Frontiers in bioengineering and biotechnology·2025
Same author

Establishing a scalable perfusion strategy for the manufacture of CAR-T cells in stirred-tank bioreactors using a quality-by-design approach.

Bioengineering & translational medicine·2025
Same author

Scaling up pluripotent stem cell-based therapies - considerations, current challenges and emerging technologies: perspectives from the ISCT Emerging Regenerative Medicine Working Group.

Cytotherapy·2025
Same author

On dementia, duties, and daughters. An ethical analysis of healthcare professionals being confronted with conflicts regarding filial duties in informal dementia care.

Frontiers in psychiatry·2024

Related Experiment Video

Updated: Feb 16, 2026

Efficient Differentiation of Human Pluripotent Stem Cells into Liver Cells
07:37

Efficient Differentiation of Human Pluripotent Stem Cells into Liver Cells

Published on: June 11, 2019

9.2K

[Human pluripotent stem cells and liver disorders].

Noushin Dianat1, Anne Weber1, Anne Dubart-Kupperschmitt1

  • 1INSERM U1193, Hôpital Paul Brousse, 94807 Villejuif, France - UMR S1193, Université Paris-Sud, Hôpital Paul Brousse, 94800 Villejuif, France - Département hospitalo-universitaire Hepatinov, Hôpital Paul Brousse, 94807 Villejuif, France.

Biologie Aujourd'Hui
|June 12, 2016
PubMed
Summary

This study develops protocols for generating liver cells from patient-derived stem cells to model familial hypercholesterolemia and study liver diseases. This advances in vitro disease modeling and drug screening for metabolic liver conditions.

More Related Videos

Culturing Human Pluripotent and Neural Stem Cells in an Enclosed Cell Culture System for Basic and Preclinical Research
08:05

Culturing Human Pluripotent and Neural Stem Cells in an Enclosed Cell Culture System for Basic and Preclinical Research

Published on: June 10, 2016

11.0K
Transfecting and Nucleofecting Human Induced Pluripotent Stem Cells
10:24

Transfecting and Nucleofecting Human Induced Pluripotent Stem Cells

Published on: October 5, 2011

22.0K

Related Experiment Videos

Last Updated: Feb 16, 2026

Efficient Differentiation of Human Pluripotent Stem Cells into Liver Cells
07:37

Efficient Differentiation of Human Pluripotent Stem Cells into Liver Cells

Published on: June 11, 2019

9.2K
Culturing Human Pluripotent and Neural Stem Cells in an Enclosed Cell Culture System for Basic and Preclinical Research
08:05

Culturing Human Pluripotent and Neural Stem Cells in an Enclosed Cell Culture System for Basic and Preclinical Research

Published on: June 10, 2016

11.0K
Transfecting and Nucleofecting Human Induced Pluripotent Stem Cells
10:24

Transfecting and Nucleofecting Human Induced Pluripotent Stem Cells

Published on: October 5, 2011

22.0K

Area of Science:

  • Hepatology and Regenerative Medicine
  • Stem Cell Biology
  • Metabolic Disease Research

Background:

  • Liver diseases, including metabolic disorders and hepatitis, lack comprehensive mechanistic understanding due to limited patient-derived cellular models.
  • Hepatocytes are crucial for xenobiotic elimination, impacting toxicology and pharmacokinetics, but studying their dysfunction in disease is challenging.
  • Induced pluripotent stem cells (iPSCs) from patients with monogenic metabolic disorders offer a valuable in vitro platform for disease mechanism studies and drug discovery.

Purpose of the Study:

  • To establish robust protocols for generating functional hepatocytes and cholangiocytes from pluripotent stem cells.
  • To develop an in vitro model for familial hypercholesterolemia using patient-derived iPSCs.
  • To advance the study of liver disease pathophysiology and facilitate drug screening.

Main Methods:

  • Generation of induced pluripotent stem cells (iPSCs) from patients with monogenic metabolic disorders.
  • Development and optimization of differentiation protocols for generating liver cells (hepatocytes and cholangiocytes) from iPSCs.
  • Disease modeling of familial hypercholesterolemia using patient-derived iPSC-derived liver cells.

Main Results:

  • Successful generation of functional cholangiocytes from pluripotent stem cells.
  • Establishment of a disease model for familial hypercholesterolemia.
  • Demonstration of the utility of iPSC-derived liver cells for studying disease mechanisms.

Conclusions:

  • Patient-derived iPSC technology provides a powerful tool for in vitro modeling of liver diseases, including familial hypercholesterolemia.
  • Robust protocols for generating liver cells are essential for advancing liver disease research and drug development.
  • This work contributes to improved understanding and potential therapeutic strategies for metabolic and other liver pathologies.